Specifically, it is the SNP (rs767455) that has been found to be involved in the regulation of TNFR1 protein expression and may potentially modulate the risk of OM in HNC patients treated with RT, and it is an independent prognostic factor of poor overall survival in HNC patients undergoing intensity-modulated radiation therapy. Here, TNFRSF1A is linked to ocular melanoma.